January 27 2005 - NEW CARDIAC DEVICE NOW AVAILABLE AT TRINITY MOTHER FRANCES HEART INSTITUTE
Press Release - January 27,
NEW CARDIAC DEVICE NOW AVAILABLE AT TRINITY MOTHER FRANCES HEART INSTITUTE
For Immediate Release
January 27, 2005
NEW CARDIAC RESYNCRONIZATION DEVICE NOW OFFERED AT TRINITY MOTHER FRANCES HEART INSTITUTE
TYLER, TX -- A Tyler Cardiovascular Consultants, PA, (CVC) physician is one of the first in the southwest to implant a new cardiac resynchronization therapy device (CRT-D) for the treatment of heart failure. Stan Weiner, MD, an electrophysiologist with CVC, implanted the new device just one week after FDA approval last month. The procedure was performed at the Trinity Mother Frances Heart Institute.
The CRT-D allows physicians to customize the synchronization by adjusting the delay between the contraction of the heart’s left and right ventricle, as well as to choose which ventricle is paced first. This is an improvement on previous devices, which did not provide an option for ventricle pulse sequencing.
“Prior to the implant, the patient was crippled by heart failure and was on oxygen therapy,” said Dr. Weiner. “Now he is now able to walk around and breathe without the aid of oxygen. He’s doing remarkable well.”
Cardiac resynchronization therapy is a new method of treating heart failure that uses electrical stimulation to coordinate the contractions of the left and right ventricle, and improve the heart’s pumping efficiency. A healthy person’s heart has four chambers that contract in synchrony to move blood throughout the body. But in patients with heart failure, obstructions to the heart’s electrical impulses disrupt the two lower chambers from contracting at the same time, thus reducing the heart’s ability to function effectively.
To help maintain the heart’s rhythm and ability to pump blood throughout the body, the implanted device monitors every heartbeat and delivers tiny electrical impulses when needed. If potentially lethal heart rhythms are detected, the CRT-D can deliver a higher level of therapy to “shock” the heart back into normal rhythm, which may prevent sudden cardiac death.
Patients with heart failure do not have a condition in which the heart abruptly stops working, rather it is caused by the heart’s inability to pump enough blood to meet the body’s demands. Symptoms include fatigue from common activities like dressing, shortness of breath and edema.
“The team of physicians of CVC and the equipment and staff of the Trinity Mother Frances Heart Institute is a partnership that continues to provide cutting-edge treatment and technology for cardiac patients in east Texas,” said Michael J. Vintges, vice president, cardiac services, Trinity Mother Frances Heart Institute. “The CRT-D is an exciting device that can instantly improve a patient’s quality of life. We are proud to add it to our extensive list of available technology for our patients.”
Other technological additions to the Trinity Mother Frances Heart Institute have included the RX ACCULINK carotid stent system and RX ACCUNET embolic protection system; AngioJetâ Thrombectomy system, a device that uses high-pressure water jets to remove blood clots, a leading cause of heart attacks; the FilterWire EX System, a filter designed to capture loose blood clot material that can be dislodged during cardiovascular interventions such as angioplasty or stenting and cause a heart attack; the Frontrunner X39 CTO Catheter, a plaque-penetrating device that can prevent the need for cardiac bypass surgery in some patients; and the 3-D Echo, a three-dimensional echocardiography diagnostic tool that provides physicians with real-time, detailed images of the heart and assists cardiologists at Mother Frances Hospital in implementing more accurate and faster treatment programs.
For more information on cardiac services available through the Trinity Mother Frances Heart Institute, visit www.tmfhs.org or call TeleCare Plus at 903-531-5678, or outside Tyler at 800-535-9799.
# # #